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duced tracer uptake in the basal ganglia (Fig. 1) .
In February 2015 she started experiencing sudden-onset respiratory crises characterized by severe hypoventilation. She was treated initially with four cycles of rituximab and two cycles of cyclophosphamide, which produced no benefit, and subsequently with four cycles of plasma exchange (each one consisting of 5 sessions), which produced a modest improvement in her mental status only. Prophylactic bilateral salpingooophorectomy was also performed, and a histopathological examination of ovarian tissue produced normal findings. Follow-up brain 18 F-FDG-PET/CT appeared to indicate remission, while brain MRI showed a minimal increase in the size of the residual glioma (Fig. 1) . In December 2015, following a particularly severe respiratory crisis, she entered a severe unremitting coma and died shortly afterwards. An autopsy was not performed.
As previously stated, anti-NMDAR encephalitis is a recently described disease with an autoimmune pathological basis. The binding of autoantibodies to the GluN1 NMDAR subunit, with consequent receptor internalization and inhibition, has been proposed as the underlying pathogenic mechanism. 1 The presentation usually follows a subacute course, with the development of behavioral abnormalities or psychiatric symptoms that are often associated with short-term memory impairment and altered mental status. 2, 3 The results of imaging findings and of CSF examination are often unremarkable, although 
the presence of lymphocytic pleocytosis or oligoclonal bands has been reported. Over half of the cases occurring in patients aged between 18 and 45 years have been reported in association with ovarian teratoma. 3 An association with brain glioma is not, to our knowledge, described in the literature. This finding, in the Authors' opinion, could also be explained by an aberrant autoimmune response to neuronal proteins. NMDAR is normally expressed on both astrocytes and oligodendrocytes; 4 therefore an immune reaction against glioma favored by the tumor microenvironment might be the underlying mechanism. However, the exact trigger remains unknown. We excluded the presence of another malignancy through an extensive diagnostic workup, including oophorectomy, but since tumors were not found in several reported cases of encephalitis, 2,3 a casual association cannot be fully excluded. Further research is needed on this topic.
Brain 18 F-FDG-PET is emerging as an important diagnostic tool for autoimmune encephalitis. 5, 6 However, the observed marked variability has made it difficult to find specific correlations between imaging findings and disease processes. In the present case we found hypometabolism in the occipital region, which is a characteristic proposed as a biomarker for early anti-NMDAR encephalitis, 5 and also in the basal ganglia, which instead contrasts with the findings of other studies. 6 Also, while the follow-up imaging showed improvement from the metabolic standpoint, the clinical status of our patient continued to worsen. Since 18 F-FDG-PET is an expensive diagnostic modality that is not widely available, further research is needed to better delineate its possible role in the diagnosis of autoimmune encephalitis.
